The Mass Spectrometry Facility houses cutting-edge mass spectrometry and proteomics technologies for the study of protein structure and function, and their relationship to human disease.
Based on a collaborative model
- Consultation to researchers interested in or engaged in biomarker identification, including basic protein identification, fractionation and an
alysis - Proteomic analyses for discovery studies, using in-gel and gel-free technologies
- Design and development of Mass spectrometry-based research diagnostics and/or ELISA assays.
Based on a fee-for-service model
- A range of NATA certified assays for steroids, metanephrines, vitamins and drugs
- Assay service for research groups.
Contact
Dr Andrew Stephens
Head, Ovarian Cancer Biomarker Laboratory
Hudson Institute
t:+61 3 8572 2686
e: andrew.n.stephens@hudson.org.au
Dr George Streitberg
Principal Scientist
Biochemistry
Monash Health
t:+61 3 9594 2055
e: george.streitberg@monashhealth.org